Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
110946716 | 11094671 | 6 | F | 2006 | 20160824 | 20150506 | 20160826 | EXP | US-PFIZER INC-2014027074 | PFIZER | 55.00 | YR | M | Y | 68.00000 | KG | 20160826 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
110946716 | 11094671 | 1 | PS | LYRICA | PREGABALIN | 1 | 1800 MG, DAILY | J11143 | 21446 | 1800 | MG | CAPSULE, HARD | |||||||
110946716 | 11094671 | 2 | SS | LYRICA | PREGABALIN | 1 | Oral | 100 MG, 4X/DAY | 21446 | 100 | MG | CAPSULE, HARD | QID | ||||||
110946716 | 11094671 | 3 | SS | LYRICA | PREGABALIN | 1 | Oral | 100 MG, 4X/DAY | 21446 | 100 | MG | CAPSULE, HARD | QID | ||||||
110946716 | 11094671 | 4 | SS | LYRICA | PREGABALIN | 1 | Oral | 100 MG, 4X/DAY | 21446 | 100 | MG | CAPSULE, HARD | QID | ||||||
110946716 | 11094671 | 5 | C | PROAIR HFA | ALBUTEROL SULFATE | 1 | 90 MCG/ACTUATION INHALER INHALE 2 PUFFS EVERY 4 HOURS AS NEEDED AND PRIOR TO EXERCISE IF NEEDED | 0 | 2 | DF | |||||||||
110946716 | 11094671 | 6 | C | ASPIRIN (E.C.) | ASPIRIN | 1 | Oral | 81 MG, DAILY | 0 | 81 | MG | TABLET | |||||||
110946716 | 11094671 | 7 | C | KLONOPIN | CLONAZEPAM | 1 | Oral | 1 MG, 2X/DAY AS NEEDED | 0 | 1 | MG | TABLET | BID | ||||||
110946716 | 11094671 | 8 | C | XYLOCAINE | LIDOCAINE HYDROCHLORIDE | 1 | 2 % JELLY A SMALL AMOUNT TO AFFECTED AREA TWICE A DAY AS NEEDED | 0 | 2 | PCT | BID | ||||||||
110946716 | 11094671 | 9 | C | MS CONTIN | MORPHINE SULFATE | 1 | Oral | 60 MG, 2X/DAY | 0 | 60 | MG | TABLET | BID | ||||||
110946716 | 11094671 | 10 | C | MSIR | MORPHINE SULFATE | 1 | Oral | 15 MG, 3X/DAY AS NEEDED | 0 | 15 | MG | TABLET | TID | ||||||
110946716 | 11094671 | 11 | C | ZOLOFT | SERTRALINE HYDROCHLORIDE | 1 | Oral | 100 MG, 1X/DAY EVERY MORNING | 0 | 100 | MG | TABLET | QD | ||||||
110946716 | 11094671 | 12 | C | ZOLOFT | SERTRALINE HYDROCHLORIDE | 1 | Oral | 100 MG, 1X/DAY EVERY MORNING | 0 | 100 | MG | TABLET | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
110946716 | 11094671 | 1 | Neuralgia |
110946716 | 11094671 | 7 | Anxiety |
110946716 | 11094671 | 8 | Pain |
110946716 | 11094671 | 10 | Pain |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
110946716 | 11094671 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
110946716 | 11094671 | Drug ineffective | |
110946716 | 11094671 | Ear pain | |
110946716 | 11094671 | Eye pain | |
110946716 | 11094671 | Intentional product misuse | |
110946716 | 11094671 | Movement disorder | |
110946716 | 11094671 | Neuropathy peripheral | |
110946716 | 11094671 | Pain | |
110946716 | 11094671 | Prescribed overdose |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
110946716 | 11094671 | 1 | 2006 | 0 | ||
110946716 | 11094671 | 2 | 20151201 | 0 | ||
110946716 | 11094671 | 3 | 20160315 | 0 | ||
110946716 | 11094671 | 4 | 20160823 | 0 | ||
110946716 | 11094671 | 5 | 20160304 | 0 | ||
110946716 | 11094671 | 7 | 20160304 | 0 | ||
110946716 | 11094671 | 8 | 20090407 | 0 | ||
110946716 | 11094671 | 9 | 20160304 | 0 | ||
110946716 | 11094671 | 10 | 20160304 | 0 | ||
110946716 | 11094671 | 11 | 20160301 | 0 | ||
110946716 | 11094671 | 12 | 20160304 | 0 |